$26.24
0.210.81%
At close: -
$26.06
-0.18-0.69%
After Hours: 4:11 PM EDT
Pacira BioSciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Pacira BioSciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-06 | $0.79 | $0.70 | 12.9 % |
Q2 | 2024-07-30 | $0.89 | $0.70 | 27.1 % |
Q1 | 2024-05-07 | $0.62 | $0.62 | 0.00 % |
Q4 | 2024-02-29 | $0.89 | $0.88 | 1.14 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-06 | $168.57M | $169.67M | -0.65 % |
Q2 | 2024-07-30 | $178.02M | $172.48M | 3.21 % |
Q1 | 2024-05-07 | $167.12M | $165.35M | 1.07 % |
Q4 | 2024-02-29 | $181.24M | $181.66M | -0.23 % |
Pacira BioSciences (PCRX) is scheduled to report earnings on February 27, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $0.79, which beat the estimate of $0.70.
The Actual Revenue was $168.6M, which missed the estimate of $169.7M.
Browse earnings estimates, EPS, and revenue on all stocks.